Peptide and Anticoagulant Drugs Market by Type (Antifungal, Hormonal, Ace Inhibitors, Antibiotic, and Other Drugs), by Low Molecular Weight Heparin Type (Heparin Sodium, Enoxaparin Sodium, Dalteparin Sodium, and Fondaparinux), and by Application (Infectious Diseases, Gynecology, Cancer, Diabetes, Cardiology, Osteoporosis, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-Aug-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3130 Status : Published

Global peptide and anticoagulant drugs market expected to generate around USD 1,860 million by 2025, at a CAGR of around 4.6% between 2019 and 2025. Anticoagulants drugs are referred to as blood thinners. It is a form of chemical substance that prevents the delay in clotting time and helps to keep the affected area unclotted for a longer time period.

Request methodology of Peptide and Anticoagulant Drugs Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com